Is the Use of 9/10 HLA Unrelated Donors Still Acceptable in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies? Comparison with Transplants from 10/10 HLA Unrelated Donors and Siblings
Marie‐Cécile Michallet(Université Claude Bernard Lyon 1), F-E Nicolini, Nathalie Tedone(Hospices Civils de Lyon), Stéphane Morisset(Lyon 1 Université), Fiorenza Barraco(Hôpital Lyon Sud), Youcef Chelghoum(Hôpital Edouard Herriot), Mohamed Sobh(Hospices Civils de Lyon), X. Thomas(Hôpital Edouard Herriot), Sophie Ducastelle(Hôpital Lyon Sud), Hélène Labussière(Hôpital Lyon Sud), Marie Y. Detrait(Hôpital Civil de Charleroi)
Cited by 0
Related Papers
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
|Leukemia|2013|233